Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer.
Saved in:
| Title: | Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer. |
|---|---|
| Authors: | Schniewind I; National Center for Tumor Diseases (NCT), Faculty of Medicine, University Hospital Carl Gustav Carus, Dresden University of Technology, 01307 Dresden, Germany.; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus, Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf, 01307 Dresden, Germany.; Department of Neurology, Carl Gustav Carus University Hospital, Dresden University of Technology, 01307 Dresden, Germany., Besso MJ; German Cancer Research Center (DKFZ), Division Radiooncology/Radiobiology, 69120 Heidelberg, Germany., Klicker S; National Center for Tumor Diseases (NCT), Faculty of Medicine, University Hospital Carl Gustav Carus, Dresden University of Technology, 01307 Dresden, Germany., Schwarz FM; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus, Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf, 01307 Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, 01307 Dresden, Germany.; Institute of Radiooncology-OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01307 Dresden, Germany., Hadiwikarta WW; German Cancer Research Center (DKFZ), Division Radiooncology/Radiobiology, 69120 Heidelberg, Germany., Richter S; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Carl Gustav Carus, Dresden University of Technology, 01307 Dresden, Germany., Löck S; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus, Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf, 01307 Dresden, Germany.; Department of Radiation Oncology, University Hospital Carl Gustav Carus, 01307 Dresden, Germany., Linge A; National Center for Tumor Diseases (NCT), Faculty of Medicine, University Hospital Carl Gustav Carus, Dresden University of Technology, 01307 Dresden, Germany.; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus, Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf, 01307 Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, 01307 Dresden, Germany.; Department of Radiation Oncology, University Hospital Carl Gustav Carus, 01307 Dresden, Germany., Krause M; National Center for Tumor Diseases (NCT), Faculty of Medicine, University Hospital Carl Gustav Carus, Dresden University of Technology, 01307 Dresden, Germany.; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus, Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf, 01307 Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, 01307 Dresden, Germany.; Institute of Radiooncology-OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01307 Dresden, Germany.; Department of Radiation Oncology, University Hospital Carl Gustav Carus, 01307 Dresden, Germany., Dubrovska A; National Center for Tumor Diseases (NCT), Faculty of Medicine, University Hospital Carl Gustav Carus, Dresden University of Technology, 01307 Dresden, Germany.; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus, Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf, 01307 Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, 01307 Dresden, Germany.; Institute of Radiooncology-OncoRay, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01307 Dresden, Germany., Baumann M; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus, Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf, 01307 Dresden, Germany.; German Cancer Research Center (DKFZ), Division Radiooncology/Radiobiology, 69120 Heidelberg, Germany., Kurth I; German Cancer Research Center (DKFZ), Division Radiooncology/Radiobiology, 69120 Heidelberg, Germany., Peitzsch C; National Center for Tumor Diseases (NCT), Faculty of Medicine, University Hospital Carl Gustav Carus, Dresden University of Technology, 01307 Dresden, Germany.; OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus, Dresden University of Technology and Helmholtz-Zentrum Dresden-Rossendorf, 01307 Dresden, Germany.; Center for Regenerative Therapies Dresden (CRTD), Dresden University of Technology, 01307 Dresden, Germany. |
| Source: | Cancers [Cancers (Basel)] 2024 Feb 09; Vol. 16 (4). Date of Electronic Publication: 2024 Feb 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2072-6694 |
|---|---|
| DOI: | 10.3390/cancers16040730 |
